US Patent Issued to DIZAL (JIANGSU) PHARMACEUTICAL on May 19 for "DNA-dependent protein kinase inhibitor" (Chinese Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,565, issued on May 19, was assigned to DIZAL (JIANGSU) PHARMACEUTICAL Co. LTD. (Shanghai).

"DNA-dependent protein kinase inhibitor" was invented by Changhe Qi (Shanghai), Honchung Tsui (Shanghai), Qingbei Zeng (Shanghai), Zhenfan Yang (Shanghai) and Xiaolin Zhang (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are compounds of Formula (I), and pharmaceutically acceptable salts thereof, that are useful as DNA-PK inhibitors. Also disclosed are pharmaceutical compositions comprising one or more compounds of Formula (I), and methods of using such compounds or compositions to treat DNA-PK related disorder (e.g., cancer)."

The pa...